rabeprazole has been researched along with Adamantiades-Behcet Disease in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xia, Q | 1 |
| Lyu, C | 1 |
| Li, F | 1 |
| Pang, B | 1 |
| Guo, X | 1 |
| Ren, H | 1 |
| Xing, Y | 1 |
| Chen, Z | 1 |
1 other study available for rabeprazole and Adamantiades-Behcet Disease
| Article | Year |
|---|---|
Candidate Drugs Screening for Behcet's Disease Based on Bioinformatics Analysis and Mouse Experiments.
Topics: Animals; Behcet Syndrome; Computational Biology; Cytokines; Gene Expression Profiling; Inflammation; | 2022 |